New labeling on extended-release stimulant medications raises questions about the best treatment for ADHD in young children. However, treatment recommendations—which put behavioral management and parent training ahead of medications and recommend holding off on prescribing medications until later—have not changed. The US Food and Drug Administration now requires extended-release stimulant medications to carry a warning…